EUCOPE's #LifeScienceLectures - Episode Two "Defining High Unmet Medical Need (HUMN)"

EHA 2024 | Whose needs exactly? Unmet medical need in the EU pharmaceutical legislation

Orphan Drug Development | Episode 06 - USFDA vs EMA : Orphan Drug Designation | Regulatory Affairs

The EMA perspective on drug approval process in the era of precision medicine

Webinar on revision of the pharmaceutical legislation

Unmet Therapeutic Needs: What Are They and Can We Find the Fixes?

Medical Device Regulation

Public System Demo Q3/2024

EMA & EATRIS present: Scientific Advice for Advanced Therapy Medicinal Products: What & When to Ask

FDA-EMA Parallel Scientific Advice (PSA) Program

EU ATMPs Quality Regulation

Are current investments in medical research focusing on unmet health needs?

EU HTA Regulation Insights: Expert Strategies for Success

EMA workshop on haemoglobinopathies

Required and Enhanced RWHAP Unmet Need Estimates and Analyses: Exploring the Possibilities

Microbiome Products as Drugs: EU and US Definitions

IMT Use Case: How to apply and benefit from an ODD

Webinar Pilot to provide Scientific Advice to manufactures on certain high risk Medical Devices

Information session on the pilot for expert panels' advice for orphan medical devices

2021 T1D Workshop- EMA perspective | Peter Mol